Harikrishna Devalapally
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 1%
Papers in
-
- Nanoparticle-Based Drug Delivery 8
-
- RNA Interference and Gene Delivery 2
- Cancer therapeutics and mechanisms 2
- Co-authors
- Mansoor M. Amiji (10 shared papers)Srinivas Ganta (2 shared papers)Aliasgar Shahiwala (1 shared paper)Zhenfeng Duan (2 shared papers)Michael V. Seiden (2 shared papers)Dinesh B. Shenoy (2 shared papers)Róbert Langer (1 shared paper)Steven R. Little (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Journal of Controlled Release (2 papers)Drug Delivery (1 paper)Archives of Pharmacal Research (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesIndiaMexico
In The Last Decade
Harikrishna Devalapally
18 papers receiving 3.0k citations
Harikrishna Devalapally's Hit Papers
Peers
Comparison fields: 5 of 126
- Biomaterials 1.5k
- Molecular Medicine 340
- Pharmaceutical Science 377
- Surfaces, Coatings and Films 193
- Biomedical Engineering 1.0k
Countries citing papers authored by Harikrishna Devalapally
This map shows the geographic impact of Harikrishna Devalapally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harikrishna Devalapally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harikrishna Devalapally more than expected).
Fields of papers citing papers by Harikrishna Devalapally
This network shows the impact of papers produced by Harikrishna Devalapally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harikrishna Devalapally. The network helps show where Harikrishna Devalapally may publish in the future.
Co-authors
The 25 scholars most cited alongside Harikrishna Devalapally, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A review of stimuli-responsive nanocarriers for drug and gene delivery Hit paper breakdown → | 2008 | 1934 |
| 2 | 2009 | 214 | |
| 3 | 2007 | 185 | |
| 4 | 2008 | 149 | |
| 5 | 2006 | 136 | |
| 6 | 2010 | 120 | |
| 7 | 2008 | 105 | |
| 8 | 2007 | 91 | |
| 9 | 2007 | 31 | |
| 10 | 2008 | 28 | |
| 11 | 2013 | 25 | |
| 12 | 2013 | 24 | |
| 13 | 2008 | 22 | |
| 14 | 2008 | 16 | |
| 15 | 2013 | 15 | |
| 16 | 2008 | 8 | |
| 17 | 2008 | 4 | |
| 18 | 2011 | 4 |
About Harikrishna Devalapally
Harikrishna Devalapally is a scholar working on Biomaterials, Molecular Biology, Pharmaceutical Science, Organic Chemistry and Biomedical Engineering, having authored 18 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers), Synthesis and Biological Evaluation (3 papers), Inhalation and Respiratory Drug Delivery (2 papers), RNA Interference and Gene Delivery (2 papers), Cancer therapeutics and mechanisms (2 papers) and Gold and Silver Nanoparticles Synthesis and Applications (1 paper). The work is most often cited by research in Biomaterials (1.5k citations), Molecular Medicine (340 citations), Pharmaceutical Science (377 citations), Surfaces, Coatings and Films (193 citations) and Biomedical Engineering (1.0k citations). Harikrishna Devalapally has collaborated with scholars based in United States, India and Mexico. Frequent co-authors include Mansoor M. Amiji, Srinivas Ganta, Aliasgar Shahiwala, Zhenfeng Duan, Michael V. Seiden, Dinesh B. Shenoy, Róbert Langer, Steven R. Little, Mayank Bhavsar and Ziedonis Skobe. Their work appears in journals such as Journal of Pharmaceutical Sciences, Journal of Controlled Release, Drug Delivery, Archives of Pharmacal Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.